The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. OPKO Health Inc. shares valued at $802,103 were purchased by FROST PHILLIP MD ET AL on Aug 05. At $2.29 per share, FROST PHILLIP MD ET AL acquired 350,000 shares. The insider’s holdings grew to 196,956,694 shares worth approximately $492.39 million following the completion of this transaction.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Also, Nabel Gary J. purchased 240,000 shares, netting a total of over 597,393 in proceeds. Following the buying of shares at $2.49 each, the insider now holds 19,857,514 shares.
Before that, FROST PHILLIP MD ET AL had added 200,000 shares to its account. In a trade valued at $478,857, the CEO & Chairman bought OPKO Health Inc. shares for $2.39 each. Upon closing the transaction, the insider’s holdings increased to 200,000 shares, worth approximately $491.52 million.
As published in a research note from Barrington Research on January 24, 2022, OPKO Health Inc. [OPK] has been rated down from an Outperform to a Mkt perform. Analysts at Ladenburg Thalmann started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. As of November 25, 2019, Piper Jaffray has initiated its “an Overweight” rating for OPK. Earlier on March 02, 2018, JP Morgan downgraded its rating. Their new recommendation was “an Underweight” for OPK stock which previously was a “a Neutral”.
Analyzing OPK’s Price Performance
On Thursday, OPKO Health Inc. [NASDAQ: OPK] plunged -7.75% to $2.50. The stock’s lowest price that day was $2.50, but it reached a high of $2.77 in the same session. During the last five days, there has been a surge of approximately 4.17%. Over the course of the year, OPKO Health Inc. shares have dropped approximately -48.02%. Shares of the company reached a 52-week high of $4.95 on 01/03/22 and a 52-week low of $2.15 on 08/05/22. A 50-day SMA is recorded $2.59, while a 200-day SMA reached $3.35. Nevertheless, trading volume fell to 3.2 million shares from 6.65 million shares the previous day.
Support And Resistance Levels for OPKO Health Inc. (OPK)
According to the 24-hour chart, there is a support level at 2.41, which, if violated, would cause prices to drop to 2.32. In the upper region, resistance lies at 2.68. The next price resistance is at 2.86. RSI (Relative Strength Index) is 48.74 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.13, which suggests the price will decrease in the coming days. Percent R is at 43.90%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is OPKO Health Inc. subject to short interest?
Stocks of OPKO Health Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -5.55 million shares to 48.68 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 54.23 million shares. A decline of -11.4% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.93 of the overall float, the days-to-cover ratio (short ratio) decline to 9.93.
Which companies own the most shares of OPKO Health Inc. (OPK)?
According to The Vanguard Group, Inc. filings, the company currently owns 35,416,597 shares, which is about 5.20% of the total OPK shares outstanding. The investor’s shares have appreciated by 401,575 from its previous 13-F filing of 35015022.0 shares. With the completion of the sale transaction, BlackRock Fund Advisors’s stake is now worth $72,330,919. SSgA Funds Management, Inc. acquire a 56.66% interest valued at $70.05 million while Oracle Investment Management, Inc sold a -3,233,317 stake. A total of 37,079 shares of OPKO Health Inc. were sold by Geode Capital Management LLC during the quarter, and 3,037,320 were bought by Dimensional Fund Advisors LP. In its current portfolio, Northern Trust Investments, Inc. holds 5,734,926 shares valued at $14.51 million.
In terms of OPKO Health Inc. share price expectations, FactSet research, analysts set an average price target of $5.69 in the next 12 months, up nearly 89.3% from the previous closing price of $2.71. Analysts anticipate OPKO Health Inc. stock to reach $8.50 by 2022, with the lowest price target being $4.00. In spite of this, 5 analysts ranked OPKO Health Inc. stock as a Buy at the end of 2022.